Trial
NCT04657679
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Medstar Health Research Institute; Breast Cancer Research Foundation; Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS); National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
Ribociclib
Why stopped
Sufficient accrual into the African American/Black patient cohort and insufficient accrual into the NHW patient cohort.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-26